Lysodren for Adrenocortical carcinoma
Quick answer: Lysodren is used for Adrenocortical carcinoma as part of a adrenal cytotoxic agent treatment regimen. Selectively toxic to adrenal cortex cells, suppressing cortisol production and causing adrenocortical atrophy The specific dosing for Adrenocortical carcinoma is determined by your prescriber based on individual factors.
Why is Lysodren used for Adrenocortical carcinoma?
Lysodren belongs to the Adrenal cytotoxic agent class. Selectively toxic to adrenal cortex cells, suppressing cortisol production and causing adrenocortical atrophy This action makes it useful for treating or managing Adrenocortical carcinoma in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Lysodren is the right choice for a specific patient depends on the type and severity of Adrenocortical carcinoma, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Adrenocortical carcinoma
Common adult dosing range: Mitotane 2-6 g daily in divided doses. The actual dose for Adrenocortical carcinoma depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Lysodren medicine page.
What to expect
Lysodren treatment for Adrenocortical carcinoma typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Adrenocortical carcinoma
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Lysodren is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Adrenal cytotoxic agent for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Lysodren
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Lysodren full prescribing information · All Adrenal cytotoxic agent alternatives
Frequently asked questions
How effective is Lysodren for Adrenocortical carcinoma?
Effectiveness varies by individual response, dose, and severity. Lysodren is one of several treatment options for Adrenocortical carcinoma, supported by clinical evidence within the adrenal cytotoxic agent class. Discuss expected response with your prescriber.
How long do I need to take Lysodren for Adrenocortical carcinoma?
Treatment duration depends on the nature of Adrenocortical carcinoma — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Lysodren when used for Adrenocortical carcinoma?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Lysodren for Adrenocortical carcinoma?
Yes. Multiple medicines and non-drug options exist for Adrenocortical carcinoma. Alternatives within the adrenal cytotoxic agent class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.